The software incorporates existing digital technology, such as embedded algorithms based on national and international guidelines, alongside the patient's own medical records, to provide a computer-guided consultation for asthma and COPD annual reviews either remotely or face-to-face.
The software provides support for healthcare professionals to perform high quality and consistent reviews to national and international standards, promoting purposeful history taking and providing prompts to consider guideline-based treatment interventions, regardless of clinical expertise.
The technology incorporates a comprehensive data dashboard to view outputs and can be used remotely or in-person to guide and inform appropriate action at annual reviews, involving the patient in decision-making at each stage to ensure they are fully engaged in the management of their condition.
Additionally, the software signposts community support available such as pulmonary rehabilitation services and smoking cessation and provides clinical prompts to upskill healthcare professionals for the future. The technology aims to streamline patient care and reduce the burden on healthcare providers by improving the efficiency of reviews.
It has been estimated that NHS England may be able to make up to £65.6m savings in Year 1 assuming all practices implement the LungHealth software.
Ralph Blom, general manager at Chiesi UK and Ireland, said: ‘This partnership is integral to delivering better care for people with respiratory diseases, easing healthcare workloads, and meeting the unmet needs of our local communities. We're excited to see the positive impact it can have.'
Dr Tracey Vell, Medical Director, Health Innovation Manchester, said: ‘The software will help clinical reviews of patients for busy GP practices and ensure patients are provided with the optimal care.
‘The implementation of the LungHealth software will enable more efficient reviews in line with the very latest guidance, easing the burden on Primary Care, with better care for patients.'
